TransCode Therapeutics, Inc. (RNAZ)

TransCode Therapeutics Statistics

Total Valuation

RNAZ has a market cap or net worth of $6.38 million. The enterprise value is $2.32 million.

Market Cap	6.38M
Enterprise Value	2.32M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

RNAZ has 833,619 shares outstanding.

Current Share Class	833,619
Shares Outstanding	833,619
Shares Change (YoY)	n/a
Shares Change (QoQ)	+37.07%
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	58.39%
Float	23.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-4.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.56

Current Ratio	2.56
Quick Ratio	2.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-584.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-157.06%
Return on Invested Capital (ROIC)	-17,645.14%
Return on Capital Employed (ROCE)	-346.27%
Revenue Per Employee	n/a
Profits Per Employee	-$2.39M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.87% in the last 52 weeks. The beta is 1.53, so RNAZ's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	-98.87%
50-Day Moving Average	16.05
200-Day Moving Average	220.93
Relative Strength Index (RSI)	32.12
Average Volume (20 Days)	367,432

Short Selling Information

Short Interest	1.14M
Short Previous Month	1.04M
Short % of Shares Out	n/a
Short % of Float	4.90%
Short Ratio (days to cover)	0.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.66M
Pretax Income	-17.06M
Net Income	-16.75M
EBITDA	-15.57M
EBIT	-15.66M
Earnings Per Share (EPS)	-$1,317.42

Balance Sheet

The company has $5.81 million in cash and $38,291 in debt, giving a net cash position of $5.77 million or $6.92 per share.

Cash & Cash Equivalents	5.81M
Total Debt	38,291
Net Cash	5.77M
Net Cash Per Share	$6.92
Equity (Book Value)	-2.02M
Book Value Per Share	-54.93
Working Capital	4.32M

Cash Flow

In the last 12 months, operating cash flow was -$13.34 million and capital expenditures -$21,761, giving a free cash flow of -$13.36 million.

Operating Cash Flow	-13.34M
Capital Expenditures	-21,761
Free Cash Flow	-13.36M
FCF Per Share	-$16.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNAZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-207.04%
FCF Yield	-165.06%

Analyst Forecast

The average price target for RNAZ is $280.00, which is 3,560.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$280.00
Price Target Difference	3,560.13%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-78.60%

Stock Splits

The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.030303:1.

Last Split Date	Dec 4, 2024
Split Type	Reverse
Split Ratio	0.030303:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2